Page
%P
-
Article
Open AccessPROX1 is a predictor of survival for gliomas WHO grade II
The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers ...
-
Article
Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas
The management of adult patients with grade 2 gliomas remains a challenge for the clinical neuro-oncologist. Several clinical prognostic factors appear to be as important as treatment factors in determining ou...